Publications by authors named "Edurne Mugarza"

Claim this Profile
S
Spatial multiplex analysis of lung cancer reveals that regulatory T cells attenuate KRAS-G12C inhibitor-induced immune responses.
Megan Cole, Panayiotis Anastasiou, Claudia Lee, Xiaofei Yu, Andrea de Castro, Edurne Mugarza

Sci Adv· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combining RAS(ON) G12C-selective inhibitor with SHP2 inhibition sensitises lung tumours to immune checkpoint blockade.
Panayiotis Anastasiou, Christopher Moore, Sareena Rana, Mona Tomaschko, Claire E Pillsbury, Edurne Mugarza

Nat Commun· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CRISPR-Cas9 Screening Identifies KRAS-Induced COX2 as a Driver of Immunotherapy Resistance in Lung Cancer.
Jesse Boumelha, Andrea de Castro, Nourdine Bah, Hongui Cha, Sophie de Carné Trécesson, Edurne Mugarza

Cancer Res· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CAR-T cell therapy targeting surface expression of TYRP1 to treat cutaneous and rare melanoma subtypes.
Sameeha Jilani, Justin D Saco, Edurne Mugarza, Aleida Pujol-Morcillo, Jeffrey Chokry

Nat Commun· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Immunogenic Model of KRAS-Mutant Lung Cancer Enables Evaluation of Targeted Therapy and Immunotherapy Combinations.
Jesse Boumelha, Sophie de Carné Trécesson, Emily K Law, Pablo Romero-Clavijo, Matthew A Coelho, Edurne Mugarza

Cancer Res· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic KRAS inhibition drives effective interferon-mediated antitumor immunity in immunogenic lung cancers.
Edurne Mugarza, Febe van Maldegem, Jesse Boumelha, Christopher Moore, Sareena Rana

Sci Adv· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterisation of tumour microenvironment remodelling following oncogene inhibition in preclinical studies with imaging mass cytometry.
Febe van Maldegem, Karishma Valand, Megan Cole, Harshil Patel, Mihaela Angelova, Edurne Mugarza

Nat Commun· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of combination therapies to maximize the impact of KRAS-G12C inhibitors in lung cancer.
Miriam Molina-Arcas, Christopher Moore, Sareena Rana, Febe van Maldegem, Edurne Mugarza

Sci Transl Med· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GLP-1 nanomedicine alleviates gut inflammation.
Arivarasu N Anbazhagan, Mentor Thaqi, Shubha Priyamvada, Dulari Jayawardena, Anoop Kumar, Edurne Mugarza

Nanomedicine· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis